دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 4,800,000 تومان- قیمت ویژه : 2,400,000تومان
Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
Trusting the True Experts Through Patient-Reported Health Status in Hypertrophic Cardiomyopathy
Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy
Echocardiographic Changes With Aficamten: A Pixel Is Worth 1,024 Bits
Effect of Aficamten on Cardiac Structure and Function in Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM CMR Substudy
Unveiling the Unseen: Myosin Inhibitors Cause Reverse Remodeling of Left Ventricular Macrostructure and Microstructure by CMR
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
Cardiac Myosin Inhibitors: Is the Emperor Wearing Any Clothes, or Is it Placebo?
Aficamten in Hypertrophic Cardiomyopathy: Roots and Branches of SEQUOIA
Standard-of-Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCM
Cardiac Myosin Inhibition in Obstructive Hypertrophic Cardiomyopathy: Can Aficamten Stand Alone?
Family Screening in Hypertrophic Cardiomyopathy: Identification of Relatives With Low Yield From Systematic Follow-Up
The Apple May Fall Far From the Family Tree in Hypertrophic Cardiomyopathy
2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2024 Perioperative Cardiovascular Management for Noncardiac Surgery Guideline-at-a-Glance
